Dyno Therapeutics
Cambridge
About Dyno Therapeutics
Dyno Therapeutics is pioneering an artificial intelligence (AI) powered approach to gene therapy. Using machine learning and quantitative high-throughput in vivo experimentation, we are inventing new ways to design gene vectors with a focus on cell-targeting capsid proteins from adeno-associated virus (AAV), the most widely-used vector for gene therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $109.0M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2021)
- Website: dynotx.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/dyno-therapeutics-123207 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.